Numbers analysed
At the end of the study, the loss to follow-up was 5.4% (33/614 participants), with no significant differences between groups: 6.5% in the CG (20/306 participants) and 4.2% in the IG (13/308 participants). However, the analysis was based on the intention-to-treat principle and, therefore, included all randomised participants.